EDElvira A. Domonova

Elvira A. Domonova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elvira A. Domonova has a total of 188 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical case: Kaposi’s varicelliform eruption caused by HSV-2 in an adolescent

    by E. Yu. Evdokimov, E. V. Svechnikova, P. V. Vlasov, E. S. Dzottsoeva, Z. B. Ponezheva, E. A. Domonova, D. S. Khanova, Е. V. Melekhina

    Eczema herpeticum (Kaposi’s varicelliform eruption) is a disease characterized by an intoxication syndrome associated with a viral infection in children with atopic dermatitis. The most common etiological agent of eczema herpeticum is herpes simplex virus type 1 (HSV-1), less frequently herpes simplex virus type 2 (HSV-2), and, in rare cases, Coxsackievirus A16 or the vaccinia virus. The disease is typical for children aged 6 months to 2 years. This article presents a clinical case of eczema herpeticum in a 14-year-old adolescent with a burdened premorbid background, infected with several human herpesviruses simultaneously (Epstein-Barr virus (EBV), HSV-1, HHV-7) and an active infection caused by herpes simplex virus type 2. The etiological verification of the diagnosis using molecular genetic methods and enzyme immunoassay is described. The patient received systemic therapy, which included antiviral agent (acyclovir 500 mg IV 3 times daily for 5 days), infusion (0.9% sodium chloride 250 ml 2 times daily for 3 days), systemic anti-inflammatory agent (prednisolone 60 mg 2 times daily for 3 days), desensitizing agent (chloropyramine 25 mg 2 times daily for 5 days); local treatment with anti-inflammatory and antifungal/antibacterial agents (hydrocortisone + natamycin + neomycin 15 g 3 times daily for 7 days); drying and anti-inflammatory agent (zinc oxide 25 mg 2 times daily for 5 days), antibacterial eye drops (sulfacetamide 0.1 ml 4 times daily for 5 days). The treatment resulted in a significant improvement of the patient’s condition. The presented case of a typical clinical course of Kaposi’s varicelliform eruption has a scientific and practical significance in terms of the atypical age of disease manifestation and the etiology of the infectious process associated with patient’s burdened pre-comorbidities anamnesis. The presented case of a typical clinical course of eczema herpeticum is of scientific and practical interest due to the atypical age of disease manifestation and the etiology of the infectious process associated with the patient’s burdened premorbid background. The presented data are intended to increase awareness among practicing physicians regarding the clinical and laboratory diagnosis of herpes skin infections in older pediatric age groups.

  • Open Access

    Characteristics of the prevalence of highrisk human papilloma virus and its genotypes in women of the Gomel city /Gomel district

    by V. P. Lohinava, E. L. Gasich, N. I. Shevchenko, A. V. Voropaeva, Zh. N. Miadzvedzeva, E. A. Domonova, О. П. Логинова

    Cervical cancer remains a serious public health problem. It is the fourth most common cancer in women worldwide, with an estimated 604,000 new cases and 342,000 deaths in 2020. Human papillomavirus (HPV) vaccination, combined with screening and treatment of precancerous lesions, is an effective and cost-effective method for preventing cervical cancer. Vaccination selection depends on the circulating HPV genotypes in different regions. This article presents the prevalence of HPV and its genetic variants in women in Gomel city and the Gomel district. HPV genotypes 16, 51, and 58 were found to be most frequently detected, with their highest prevalence in the 18-24 age group and the 25-29 age group for cervical dysplasia. According to the obtained results, the tactics of conducting vaccination against high-risk HPV for the purpose of preventing cervical cancer are justified.

  • Open Access

    Prevalence of Betapolyomavirus hominis in people at risk of developing infectious complications associated with virus reactivation

    by D. R. Prilepskaya, E. A. Domonova, O. Yu. Silveistrova, A. A. Popova, M. D. Goliusova, A. V. Pokrovskaya, M. Yu. Drokov, I. S. Saidullayeva, N. V. Purlo, M. Yu. Novikov, et al.

    Objective: to evaluate the incidence of Betapolyomavirus hominis in individuals at risk of developing infectious complications associated with virus reactivation.Materials and methods. The prospective study included 601 patients in 6 groups: hematopoietic stem cell recipients with and without established hemorrhagic cystitis, allogeneic kidney recipients, HIV-infected persons, pregnant women and a control group. Quantification of B. hominis DNA by RT PCR was performed for 1202 samples of whole venous blood and urine. The results were statistically processed using the STATTECH program.Results. The prevalence of B. hominis among people at risk of developing infectious complications ranged from 6.0% to 89.2%, depending on the study group. Allo-HSCT recipients had the highest incidence of the viral DNA presence in urine samples – 89.2% with hemorrhagic cystitis and 26.3% without it, at concentrations up to 9.3×1011 IU/ml. In the remaining groups, the viral load in urine was lower (up to 1.1×108 IU/ ml), and the detection rate was: pregnant women – 14.3%, HIV-infected persons – 10.6%, allogeneic kidney recipients – 6.0%, control group – 5.8%. The chance of detecting viral DNA in urine samples of allo-HSCT recipients with hemorrhagic cystitis is 134.7 times higher than in the control group (p<0.001). B. hominis DNA was found in whole venous blood samples: 8.4% and 21.1% of allo-HSCT recipients with and without hemorrhagic cystitis, respectively (р=0,051), HIV– infected persons – 1.4%, control group – 0.4%. Simultaneous detection of viral DNA in blood and urine presented in patients after allo-HSCT, regardless of the presence of hemorrhagic cystitis and HIV–infected persons.Conclusion. Reactivation of B. hominis continues to pose a threat to human health and life, causing various complications in patients with weakened immune systems. The obtained data on the prevalence of B. hominis are necessary for studying the diseases associated with the virus and generating an algorithm for examining patients at risk of developing infectious complications.

  • Open Access

    Molecular Biological Methods in The Etiological Diagnostics of Infective Endocarditis

    by E. O. Kotova, Zh. D. Kobalava, A. S. Pisaryuk, A. Yu. Moiseeva, E. A. Domonova

    Aim To study the role of early blood tests using the polymerase chain reaction (PCR) (before or at initial stages of antibacterial therapy, within the first 24-48 hours after diagnosis) for the diagnosis of infective endocarditis (IE) and improvement of the etiological algorithm. Material and methods The study included 154 patients with confirmed IE (DUKE, 2015) who underwent standard microbiological (culture) blood tests with a simultaneous molecular biological test (PCR study/sequencing) on the same type of biological material at the stage of primary diagnosis. Results In 117 (76.0%) examined patients, the etiologic agent was determined in blood samples by any of the methods used. Concordant results were obtained in 43 (36.8%) patients and discordant in 4 (3.4%) patients. In 29 (24.8%) patients, the causative agent of IE was determined only by the microbiological (cultural) examination of blood samples, and in 25 (21.4%) patients, only by the PCR study, including 3 cases of Bartonella spр. 23 patients had results of the microbiological (culture) blood tests that required clarification (70% CoNS, 26% gram-negative bacteria, one case of Enterococcus faecalis); 16 (69.6%) of 23 were not confirmed by the molecular biological method and were interpreted as contamination. In 1/3 of patients, the PCR blood study allowed increasing the accuracy of determining the causative agent of IE. Based on the integrated approach to the etiological diagnosis of IE, criteria for determining the causative pathogen were developed. This allowed reclassifying 9 (5.9%) diagnoses into the category of confirmed IE and to de-escalate the antibacterial therapy in every third examined patient. The microbiological and PCR studies of blood demonstrated comparable indexes of sensitivity, specificity and diagnostic accuracy [79.0, 86.0, 81.0% and 67.0, 93.0, 74.0%, respectively]. The PCR study of blood at the early stages of IE diagnosis (before or during the initial antibacterial therapy, within the first 24-48 hours after the IE diagnosis) is proposed as a control for Streptococcus spp., Staphylococcus aureus, CoNS, Enterococcus spр., and at the later stages of laboratory examination, especially in IE with an unspecified pathogen, as a priority method. Conclusion The PCR study of blood samples is a highly informative method for the etiological diagnosis of IE that allows increasing the accuracy of the pathogen identification in every third patient and, thus, prescribing an effective antibacterial therapy.


  • Open Access

    Cytokine profile of surgical patients with infective endocarditis

    by E. O. Kotova, A. S. Pisaryuk, A. V. Lokhonina, A. Y. Moiseeva, E. A. Domonova, T. A. Gusarova, J. I. Babukhina, P. V. Kakhktsyan, T. K. Fatkhudinov, Z. D. Kobalava

       Aim. To study the cytokine profile of macrophages in valve tissues in operated patients with infective endocarditis (IE), its correlation with inflammatory markers for optimization of the assessment of IE activity.  Material and methods. There were prospectively included 25 adult patients with active IE (2015Duke criteria) and 24 patients with non-IE valvular heart disease admitted for cardiac surgery (2021-2022). Laboratory and instrumental examination was conducted, including pathogen verification, as well by means of Real-Time PCR in blood/tissues of resected valves, echocardiography, and neutrophil-to-lymphocyte ratio evaluation. Valvular tissues were analyzed for macrophage phenotypic characteristics using immunohistochemistry (IHC) and for pro- and anti-inflammatory cytokine gene expression via real-time PCR.   Results. IE patients had a high proportion of secondary IE due to degenerative heart defects (n = 10, 40.0 %) and left-sided localization of IE (n = 16, 64.0 %). IHC revealed a predominance of intact pro-inflammatory CD 86+ macrophages phenotype in patients without IE compared with patients with IE [0.054 (0.029-0.073) vs. 0.008 (0.0071-0.0096), p < 0.05]. There was no significant difference in the anti-inflammatory CD 206+ macrophages phenotype. In the group of operated patients with IE, Real-Time PCR revealed significant expression of IL-1β genes (Ме [IQR] 0.0037 [0.0005-0.0155] vs. 0.0002 [0.0001-0.0026], p < 0.05) and IL-6 (Ме [IQR] 0.0034 [0.0007-0.0167] vs. 0.0005 [0.0004-0.0038], p < 0.05) compared with patients without IE. There were no significant differences in anti-inflammatory cytokines. The level of cytokine gene expression by tissue macrophages, depending on the presence of embolic events, etiological affiliation to S. aureus, as well as hospital mortality and the combined endpoint (death from all causes or recurrence of IE in 6 months after surgery) did not differ between IE patients with or without events. IL-1β had the most favorable characteristics for assessing the activity of IE (IL-1β AUC 0.816 (p = 0.02)).   Conclusion. Increased macrophages destruction with excessive release of pro-inflammatory cytokines in the valve tissue determines the uncontrolled course of IE and the need for cardiac surgery. IL-1β has a high diagnostic value for determining the inflammation activity in operated patients with IE.


  • Open Access

    Clinical Case of a Patient with Acute Tricuspid Valve Infective Endocarditis and A Multiplex Approach to Evaluation of The Complication Risk

    by E. O. Kotova, Zh. D. Kobalava, A. S. Pisaryuk, A. V. Lokhonina, A. Y. Moiseeva, E. A. Domonova, J. I. Babukhina, P. V. Kakhktsyan, Т. Kh. Fatkhudinov

    Infective endocarditis (IE) is characterized by the difficulty of diagnosis, treatment and risk assessment of an unfavorable prognosis. Currently there are no approved scales and calculators for the risk of complications and death that help the practitioner make decisions, especially in patients with isolated right-sided IE. For right-sided IE, the timing of successful surgical treatment remains uncertain. Previously developed risk calculators (Italian Rizzi calculator and French Hubert) are poorly validated in a wide population of patients with IE, especially for right-sided IE. One of the required parameters of calculators is the determination of etiological affiliation. However, with negative results of microbiological studies reaching 56-83 %, this parameter becomes uninformative. Moreover, existing risk assessment tools do not take into account the activity of the disease (including laboratory activity), which intuitively is an important guideline for every doctor in decision-making. At the moment, there is a great need for the introduction of molecular biological methods to improve the quality of etiological diagnosis and in-depth study of possible biomarkers from simple (neutrophil/lymphocytic, platelet/lymphocytic and systemic immuno-inflammatory index) to more complex (neutrophil extracellular traps, cytokine profile). We present a clinical case of a young patient with acute tricuspid valve IE with giant vegetation (28 mm), complicated by severe valvular insufficiency without signs of heart failure, recurrent embolic syndrome in the pulmonary artery system with the formation of pulmonary hypertension, determining indications for cardiac surgical treatment. The etiological affiliation of IE to Staphylococcus aureus was established only by PCR. The urgent timing of intervention was determined based on an increase in new markers — neutrophil/lymphocytic index ≥20.0, systemic immuno-inflammatory index ≥2314.0 and neutrophil extracellular traps ≥14.2, indicating an extremely high risk of death. A fundamental pathohistological study of the tissue material revealed a low content of intact CD86+ proinflammatory macrophages, probably associated with their excessive destruction and uncontrolled release of copious amounts of proinflammatory cytokines, which led to rapid and severe damage to the tricuspid valve. Thus, modern management of patients with IE should be multiplex using current methods of etiological and imaging diagnostics, and aimed at early detection of patients at adverse risk for a timely differentiated approach to conservative or cardiac surgical treatment tactics.


  • Open Access

    Current epidemiological characteristics of cervical cancer in the Russian Federation

    by O. B. Kuleshova, E. A. Domonova, V. G. Akimkin

    Background. The prevalence of cervical cancer (Cca) in Russian women makes it crucial to study modern epidemiological characteristics and adjust control measures accordingly.The aim. To analyze trends in the incidence of cervical cancer in the Russian Federation.Materials and methods. A retrospective epidemiological study was conducted on cervical cancer incidence in Russian Federation from 2008 to 2021. The materials of annual statistical data “Malignant neoplasms in Russia (morbidity and mortality)” and “Status of oncological assistance to the population of Russia” (2008–2022), data of the federal statistical reporting form No. 5 “Information about preventive vaccinations” (2021), data on the number of studies conducted (cytological study and HPV-test based on RT-PCR) in the clinical diagnostic laboratory of Central Research Institute of Epidemiology of Rospotrebnadzor (2013–2021) were used.Results and discussion. The trends of Cca incidence varied depending on the women’s age. Starting in 2016, there was a stabilization of the level of morbidity in women aged 30–49 with the subsequent decrease from 2019 due to the strengthening of secondary prevention measures, including the active introduction of HPV-test into the diagnostic schemes conducted in the Russian Federation. Increased control of cervical cancer caused a rise in the proportion of cases diagnosed at an early stage (carcinomas in situ and I–II stages Cca), the increase of detection rate of in situ carcinomas per 100 cases of Cca, the growth of the proportion of carcinomas in situ to I–II stages Cca, rise of the percentage of the cases detected actively, decrease of the number of Cca cases detected at later stages and one-year mortality index.Conclusion. The epidemiological analysis of cervical cancer incidence shows that preventive measures are effective and that there is a need to intensify and increase their coverage.


  • Modern approaches to the prevention of varicella in newborns at risk of perinatal infection

    by Koltsova I.V. Koltsova, Domonova E.A. Domonova, Silveystrova O.YU. Silveystrova, Kisteneva L.B. Kisteneva L, Lyalina E.V. Lyalina


  • Quantitative determination of Epstein–Barr virus DNA in biological materials and EBV-related lung damage in HIV-infected patients

    by Shakhgildyan V.I. Shakhgildyan, Yadrikhinskaya M.S. Yadrikhinskaya, Domonova E.A. Domonova, Orlovsky A.A. Orlovsky, Kanestri V.G. Kanestri, Yarovaya E.B. Yarovaya, Moscow Moscow City Center For Aids Prevention And Control

  • Open Access

    Awareness of Women with Different HIV Status about Papillomavirus Infection in Some Countries of Eastern Europe and Central Asia

    by Diana R. Prilepskaya, Elvira A. Domonova, Anna A. Popova, Anna V. Samarina, Yuliya I. Mayer, Izzatullo R. Yoqubov, Elena L. Gasich, Adela M. Rzayeva, Molmol M. Toitukova, Zoya K. Suvorova, et al.

    Introduction: Cervical cancer ranks fourth among the most common cancers in women worldwide. HIV-infected women account for 5 % of all cases of cervical cancer. Poor awareness of the role of human papillomavirus in the development of malignant neoplasms has a negative impact on the effectiveness of preventive measures. Objective: To compare the level of awareness of papillomavirus infection in women stratified by HIV status in some countries of Eastern Europe and Central Asia. Materials and methods: The survey using the control question technique was conducted in 2022–2024 among 600 HIV-positive and 600 HIV-negative women aged 39.6 ± 12.3 years living in the Russian Federation, the Republic of Azerbaijan, the Republic of Belarus, the Kyrgyz Republic, and the Republic of Tajikistan. The systematized data was processed automatically using an online platform. A comparative analysis of the data obtained with results of the previous study (2016–2018) was carried out. Statistical data processing was carried out using the STATTECH online service. Results: 49.8 % (95 % CI: 45.9–53.8) of HIV-positive and 33.5 % of HIV-negative (95 % CI: 29.8–37.4) women were unaware of papillomavirus infection and its effects. The statistical significance of the results was confirmed using a control question (p < 0.001). The main sources of information reported were healthcare professionals (44.5 % to 83.5 %), Internet, acquaintances (12 % to 45.5 %), and mass media (0 % to 6 %). The percentage of HIV-positive women unaware of HPV showed a 3.3-fold decrease (from 11.6 % to 3.5 %) compared to the years 2016–2018. Conclusions: Our findings indicate a lower awareness of papillomavirus infection among HIV-positive than among HIV-negative women, regardless of the region of residence. We noted a positive trend towards greater trust in medical personnel and increased awareness through obtaining information on the Internet. The need to strengthen awareness raising and education using all available resources among the population was confirmed.